$AYTU can rise in the next daysContextual immersion trading strategy idea.
Aytu BioScience has a strong upward trend.
The company develops and commercializes novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility.
Due to the spread of the COVID-19, the demand for the company's services rose.
Today Aytu BioScience received confirmation from the FDA that it may begin distribution of its COVID-19 IgG/IgM Rapid Test throughout the U.S. — finance.yahoo.com
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $1,85;
stop-loss — $1,65.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Healthcare
$XAIR can rise in the next daysContextual immersion trading strategy idea.
Beyond Air has a strong upward trend.
The company develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases.
Due to the spread of the COVID-19, the demand for the company's services rose.
A lot of people will be infected and need treatment.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $7,5;
stop-loss — $7.
Information about and take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$CVS can fall in the next daysContextual immersion trading strategy idea.
CVS Health Corporation has a strong downside trend.
Despite the spread of COVID-19 and the potential to demands rising, the company has some problems with revenue and costs.
This and other conditions can cause a fall in the share price in the next days.
So I opened a short position from $52,31;
stop-loss — $54,73.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Canopy Growth Corporation $CGCdouble bottom and positive divergence for $CGC. Watch for break out of $25.64
"Translate Bio is heading up"It hit the trend resistance, rsi broke the trend though. This stock would be healthy after it broke $13. However, weekly volume is well above average for two weeks.
$GILD can rise in the next daysContextual immersion trading strategy idea.
Gilead Sciences has a strong upward trend.
The company is developing a treatment for COVID-19 now.
Due to the spread of the virus, this company looks very attractive and has a potential for success.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $80,74;
Information about stop-loss and take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$TDOC can rise in the next daysContextual immersion trading strategy idea.
Teladoc Health has a strong upward trend.
The company is providing virtual healthcare services.
Due to the spread of the COVID-19, the demand for the company's services rose.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $139,49;
Information about stop-loss and take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Healthcare probably going to take a hit this weekCongress's coronavirus stimulus deal reached Friday night included a provision requiring health insurers to bear the full cost of coronavirus test kits and to waive copays. The federal government will pay the cost for the uninsured. This will probably hurt health insurers Monday, though it might be good for service providers.
Here's another piece of bad news: xenophobia related to the virus has angered the Chinese government, and China’s official newspaper Xinhua published a threat to cut off supply chains for the US pharmaceutical industry. If China followed through on this threat, there could be big US drug shortages, which would be bad for pharmaceutical and healthcare companies.
The whole economy will be down this week due to expanding quarantines, new travel bans, and the failure of Trump's payroll tax cut proposal, but the healthcare sector may take extra damage Monday as it bears the brunt of the cost of coronavirus testing.
Pharma bull divergence -COVIDNormally when we see a such massive drops in equity, the on balance volume also trends down.
OBV is reaching a 2-year high, as we have dropped over 30%.
This divergence suggests pharmaceuticals could outperform as the market starts consolidating.
----
Regarding the volatility due to Medicare for All proposal, supported by Bernie Sanders, it seems highly unlikely he will be the democratic candidate.
With meaningful stimulus coming, I'm swing trading the dipsToday Trump and Pence seemed to finally get serious about preventing a coronavirus recession, offering a payroll tax cut, a bailout of the cruise line industry, and a promise that coronavirus patients won't have to pay for testing. Admittedly these things are small potatoes compared to the scale of business disruptions that may be coming, but it was meaningful enough to reduce the PredictIt odds of recession in Trump's first term from 61% to 53%.
The cruise line bailout suggests that similar bailouts may be coming for airlines, energy companies, and banks if necessary. Especially as the S&P 500 approaches its ten-year trend line, I am going to be looking at buying any large dips on the theory that additional panic selling will trigger additional panic stimulus from an administration finally waking up to the political risk of an election-year recession. I will not be playing with all of my funds, obviously. This will be risk on the order of 10-20% of my portfolio. (I already made a profit from this strategy today by buying near the mid-day low.)
I wouldn't be surprised to see today's rally continue tomorrow, although the after-market movement in oil isn't promising. But even if tomorrow does turn out to be a green day, the coronavirus fear is growing as the disease spreads in the US. More downside is coming soon. I wouldn't chase today's rally; the SPX is bound to dip back toward that 10-year trend line in coming months as US economic activity continues to grind to a halt.
SOLVE.CARE - Health Care Disruptor - Accumulate BITTREX:SOLVEBTC - Accumulate
Analysis Method: Fibonacci & Wave Theory
BITTREX:SOLVEBTC healthcare on the blockchain. Cut Administration waste.
solve.care
Motto:
Making healthcare
accessible, effective,
and affordable
Problem:
In much of the developed world our population is ageing rapidly. Increased demand for care is placing an intolerable burden upon already stretched healthcare resources. Complex support infrastructures, data system silos and administrative bureaucracy have given rise to inefficiency and duplication of effort that waste billions of dollars. Incredibly, up to 30% of medical bills can go towards paying administrative costs¹. That’s simply unacceptable.
Solve.Care’s revolutionary platform will significantly improve care outcomes by dramatically reducing healthcare administration costs and substantially reducing the opportunity for duplication, waste, abuse and fraud. We expect to create major cost savings by facilitating authorised peer-to-peer transactions that delegate authority to individual stakeholders while empowering payers regarding cost control and oversight.Utilizing blockchain technology, we radically reduce the unacceptable administrative burden placed on healthcare providers and enhance the care experience of individuals
Learn: solve.care
Will update.
-AB
Pharma ETF - bull divergence!As the PPH dropped 15% below the 200sma, OBV barely moved lower compared to the drop. (Between purple vertical lines). This is considered a Bullish Divergence .
Now with a strong pullback, we are half way to reach past highs; but this time with an OBV we have not yet seen since Feb, 2018.
Ready to buy the dip!
Novavax (NVAX) - Vaccine Testing - SARS, MERS, SARS-CoV-2 (2019)This is an interesting idea based on outbreaks of SARS, MERS, and SARS-CoV-2 (2019).
Novavax successfully created vaccines for SARS, MERS, and are on track to create one for SARS-CoV-2 (2019) - ir.novavax.com
Vaccine in development for SARS-CoV-2 (2019): seekingalpha.com
Is this a good investment? If the vaccination is successful and/or coronavirus outbreak continues, it could trend upwards significantly.
Disclaimer: This is not financial advice. Just my own opinion based on research.
Important Notes: For your own safety, the CDC recommends you WASH YOUR HANDS FREQUENTLY. COVER YOUR MOUTHS WHEN YOU COUGH/SNEEZE.
XLV breakout? Watch retest, quite possibly a fakeout.Healthcare is mirroring 2015-2016's triangle breakout pattern here with an obvious move above the trendline. LOTS of people see this, and there are many people viewing this as a repeat of the post 2015 rebound. I'm not totally sold on that scenario however. 2015-2016's healthcare consolidation saw a lot of frauds busted and companies deflated. Currently, we do not really have that environment to rebound from aside from the pharma companies who are going to be taking hits for opioid litigation, and we're facing some major political headwinds. While I can see some recovery from opioid settlements, I don't think we're past that as a risk quite yet, and we're coming to face other risks from the political process.
With that said, I DO like healthcare. It tends to be less cyclical than other sectors, and unlike utilities & reit's, this defensive sector isn't going to kill you if we see a return to inflation / reflation at any point.
Watch the breakout for a retest, and keep an eye on what it does. Markets love to fake people out, especially when everyone and their mother is seeing a repeat of previous patterns in play.
BEAT- BEAST is about to be unleashed...Positional/swing tradeBEAT is your prototypical aggressive growth stock- Strong future growth potential with good earning and revenue track record ... If you can overlook its debt level.
This beast was tamed for a while after its share price skyrocketed from $25 to almost $80 , but it is ready to unleash its fury again.
But first, I think the pullback is in the store facing key resistance lvl in confluence with ichi and BB on the weekly timeframe.
In addition, short % of float is around 10%.
However, it is a bullish sign when price hovers below the key resistance lvl rather than experiencing outright price rejection.
My buy zone is between $45 to $55 for the positional trade. The long term trendline and S/R flip below this price range will act as a strong support.
Click the like button and follow me if you like my analysis :D
Novartis: Buy opportunity with split entry.NVS was among the high cap losers yesterday on the renewed coronavirus tensions and pulled back dramatically (-6.90%). This however can be the buy opportunity of the next several months as it hit the 1D MA200 (orange line) and is approaching the Higher Low trend line of the 1W Channel Up (RSI = 45.378, MACD = 1.640, ADX = 65.865).
Even though the MACD indicated the possibility of a deeper pull to the 84.00 1W Support before a meaningful rebound, we give equal probabilities for the rebound to start within the Higher Low zone. Our Target zone is 98.00 - 100.00.
** If you like our free content follow our profile (www.tradingview.com) to get more daily ideas. **
Comments and likes are greatly appreciated.